AAD
  • Meeting Program
  • Registration
  • Daily Coverage
  • Photo Gallery
  • Samples & Solutions
Topics
  • Daily Coverage
  • Photo Gallery
  • Samples & Solutions
Resources
  • Meeting Program
  • Registration
Facebook iconInstagram iconTwitter X icon
Feb 14, 2022

New session examines FDA hurdles

Session dissects the regulatory process.


Markham Luke, MD, PhD, FAAD.
Markham Luke, MD, PhD, FAAD.

U065 – FDA for Dermatologists

Date: Sunday | March 27

Time: 4:30 – 5:30 p.m.

By the time dermatologists reach for the prescription pad, the FDA has already invested years into product research and development. As such, dermatologists should understand the regulatory process behind the FDA’s pre-market evaluation of medications and devices to have an appreciation for the products they use.

Understanding FDA regulations and labeling is all a part of the session, U065 – FDA for Dermatologists. Session presenter Markham Luke, MD, PhD, FAAD, the FDA’s director of Therapeutic Performance of Generic Drugs, underscored the need for dermatologists to keep current with FDA’s guidelines.

“It is important for dermatologists to be aware of FDA-approved labeling on drugs and instructions for use of devices prior to using them,” he said. “It is equally important for dermatologists to be aware of how the products they prescribe are regulated, from approval to post-market surveillance.”

One area the FDA’s Office of Generic Drugs is currently investigating is topical drug bioequivalence — assessing the possible biologic equivalence of different proprietary drugs. Dr. Luke said this is a great example of FDA’s research engagement in the science of dermato-pharmacology.

“One key area is the potential for an in-vitro approach to bioequivalence evaluations for certain topical drugs,” he said. “Such evaluations potentially allow for more precise determinations of bioequivalence than comparative clinical endpoint bioequivalence studies that have been recommended in the past.”

During the session, Dr. Luke will explore the regulatory science behind these drugs as well as recent advances. Additionally, he will detail how the FDA monitors drug products at all levels of the supply chain, and how dermatologists can contribute to that effort.

“Drugs and medical devices may have unexpected safety issues that are identified from time to time,” he said. “It is important for dermatologists to know how to alert the FDA should that be the case. In addition, certain products have specific issues such as safety mitigation strategies for their use. Dermatologists should know some of the pathways to alert the FDA for issues related to access or safety.”

Those pathways include the use of MedWatch, the FDA’s medical product safety reporting program for health professionals, patients, and consumers. Beyond partnering with the FDA in an advisory capacity, Dr. Luke said many dermatologists assume roles in the FDA in the review of new drugs and biologics, generic drugs, and new devices.

Visit AAD DermWorld Meeting News Central for more articles.

Interesting Stories
DermWorld April | Shedding light on treatments for female pattern hair loss
Presented by AAD
DermWorld April | Shedding light on treatments for female pattern hair loss
DermWorld May | Deciding the right time for treatment
Presented by AAD
DermWorld May | Deciding the right time for treatment
DermWorld  January | Scar solutions
Presented by AAD
DermWorld January | Scar solutions
DermWorld March | Publishing profiteers
Presented by AAD
DermWorld March | Publishing profiteers
Dermworld June | Smoke and the skin
Presented by AAD
Dermworld June | Smoke and the skin
DermWorld February | Glow Up
Presented by AAD
DermWorld February | Glow Up
More in Daily Coverage
Getty Images 1474944512
2025 Innovation Academy
Clearing the way
Jun 30, 2025
Getty Images 1314008575
2025 Innovation Academy
Which side are you on?
Jun 30, 2025
Getty Images 1414022120
2025 Innovation Academy
Wrapping your head around it
Jun 30, 2025
Keyvan Nouri, MD, MBA, FAAD
2025 Innovation Academy
Dermatologists mean business
Jun 30, 2025
Getty Images 2198585392
2025 Innovation Academy
Navigating the fast and furious track of aesthetic medicine
Jun 30, 2025
Getty Images 2160192947
2025 Innovation Academy
The countdown is on!
Register here.
Jun 30, 2025
Ia 2025 Chicago
2025 Innovation Academy
There’s no place like sweet home Chicago!
Jun 13, 2025
Zack Kass
2025 Innovation Academy
The future starts now
Jun 13, 2025
Getty Images 1411481894
2025 Innovation Academy
At the intersection of biopharma and academia
Jun 13, 2025
Valerie D. Callender, MD, FAAD, and Robert S. Kirsner, MD, PhD, FAAD
2025 Innovation Academy
Notable contributions in skin health
Jun 13, 2025
Getty Images 2166425804
2025 Innovation Academy
An early look into HS
Jun 13, 2025
Dsc01993
2025 Innovation Academy
Don’t delay, register today!
Secure your spot.
Jun 13, 2025
AAD
Facebook iconInstagram iconTwitter X icon
© Ascend Media All rights reserved. DermWorld Meeting News Central is a publication of the American Academy of Dermatology.